Register entry
- Registered sites
- 1
- Active NDC listings
- 0
- Live patents
- 0
- Countries
- 1
- Base
- South Korea
Authorisation
Registered operations
Analytical testing1Active ingredient (API) manufacture1Labelling1Finished drug manufacture1Packaging1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Hugel, Inc.Registrant: Taekseung Kim | 23, Geodudanji 1-gil, Dongnae-myeon, Chuncheon-si, Gangwon-do 24398, Korea, South (KOR) | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging | 3012163998695674672 |
Compare
Comparable companies in South Korea
- Aekyung Industrial Co., Ltd.1 site · 64 NDC
- Amorepacific Group1 site · 53 NDC
- I World Pharmaceutical Co., Ltd.1 site · 48 NDC
- CELLTRION Inc1 site · 36 NDC
- LAON COMMERCE CO LTD1 site · 28 NDC
- TAI GUK PHARM. CO., LTD1 site · 28 NDC
- Lydia Co Ltd.1 site · 27 NDC
- SUNJIN BEAUTY SCIENCE CO., LTD.1 site · 27 NDC
- fmg Co.Ltd1 site · 23 NDC
- DONG IL PHARMS CO., LTD.1 site · 17 NDC
Enquiry
Common questions
- Is Taekseung Kim FDA approved?
- Taekseung Kim holds 1 FDA-registered establishment in South Korea. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Taekseung Kim's drugs manufactured?
- The FDA register lists Gangwon-do 24398. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.